Joliet IL 非小细胞肺癌临床试验
12项针对 非小细胞肺癌的研究正在 Joliet及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 距离 6 英里
- University of Chicago Medicine-Orland Park, Orland Park · 距离 14 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Northwestern Medicine Orland Park, Orland Park · 距离 14 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Hope and Healing Cancer Services, New Lenox · 距离 6 英里
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Hope and Healing Cancer Services, New Lenox · 距离 6 英里
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
招募中2 期
- Hope and Healing Clinical Research, New Lenox · 距离 6 英里
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- University of Chicago, New Lenox · 距离 6 英里
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
招募中3 期
- Northwestern Medicine Orland Park, Orland Park · 距离 14 英里
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox · 距离 6 英里
- The University of Chicago Medicine Center for Advanced Care Orland Park, Orland Park · 距离 14 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Northwestern Medicine Orland Park, Orland Park · 距离 14 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Northwestern Medicine Orland Park, Orland Park · 距离 14 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Northwestern Medicine Orland Park, Orland Park · 距离 14 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Northwestern Medicine Orland Park, Orland Park · 距离 14 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Joliet的其他研究
- 肺癌12 项研究
- 膀胱癌7 项研究
- 转移性癌症7 项研究
- 头颈鳞状细胞癌6 项研究
- 前列腺癌5 项研究
- 急性髓系白血病5 项研究
- 下咽癌5 项研究
- 喉癌5 项研究
- 口腔癌5 项研究
- 乳腺癌4 项研究
- 卵巢癌4 项研究
- 结肠癌4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。